Santen Pharmaceutical (OTCMKTS:SNPHY) was downgraded by Credit Suisse Group from an “outperform” rating to a “neutral” rating in a research note issued to investors on Monday, The Fly reports.
Shares of OTCMKTS SNPHY opened at $18.42 on Monday. The stock’s fifty day moving average price is $18.29 and its two-hundred day moving average price is $17.90. Santen Pharmaceutical has a one year low of $13.00 and a one year high of $20.18.
About Santen Pharmaceutical
Further Reading: Understanding the different types of bonds
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.